MamaLift ensures personalized care tailored to
each woman's journey through motherhood, empowering them to manage
stress, embrace joy, and reduce the risk of depression and anxiety
during and after pregnancy.
SAN
ANTONIO, Oct. 19, 2024 /PRNewswire/ -- Frost
& Sullivan assessed the women's health digital therapeutics
industry, and based on its analysis results, recognizes Curio
Digital Therapeutics with the 2024 Global New Product Innovation
Award. The company is a leading developer of innovative digital
health solutions focused on women's mental health. It utilizes a
predictive algorithm for early identification and triage of common
mental health disorders affecting women, turning data into
actionable insights. Curio then offers cutting-edge digital
self-guided cognitive behavioral therapy (CBT) programs integrated
with live health coaches, providing on-demand care. It
makes mental health support accessible to women globally, applying consistent
scientific principles across different regions to address
common mental and behavioral disorders. Its platform mitigates the
stigma surrounding mental health issues by offering anonymity, thus
empowering women to seek assistance with greater freedom and
confidence.
Curio's MamaLift is a general wellness product that manages
neurobehavioral symptoms during pregnancy and postpartum period. It
empowers mothers to manage stress, anxiety, and other
neurobehavioral symptoms by providing bite-sized digital doses of
CBT, evidence-based self management tools, insightful trackers, and
on-demand access to health coaches. Curio's "digital dose" approach
uniquely ensures user-friendliness, requiring only 10 minutes of
daily engagement. It caters to the busy lives of mothers, offering
flexibility with audio, visual, reading and gamification options
tailored to individual preferences. The platform simplifies complex
mental health challenges into small, interactive, manageable tasks,
facilitating easy integration into daily routines. Its feedback
loop allows users to rate their experiences and provide free-text
comments on each module for continuous improvement, keeping the
platform responsive and user-focused. Available 24/7, it provides
continuous support through adaptable self-guided modules customized
to each user's unique needs based on cultural values, nutritional
habits, and personal lifestyles, ensuring personalized care
throughout their motherhood journey.
Manuel Albornoz, Best Practices
Research Analyst, Frost & Sullivan, observed "Curio
distinguishes itself by building the largest body of evidence, with
seven clinical studies published, and delivering a remarkable 5:1
return on investment. Curio's comprehensive, AI-driven platform
excels in early identification and risk stratification,
significantly improving mental health outcomes for women."
Curio's MamaLift Plus, on the other hand, is a prescription-only
digital therapeutic solution intended to provide neurobehavioral
interventions to patients aged at least 22 years, as an adjunct to
clinician-managed outpatient care.
It treats mild to moderate
postpartum depression by improving a patient's symptoms
of depression. MamaLift Plus delivers digital Cognitive Behavioral
Therapy (CBT), Behavioral Activation Therapy (BAT), Interpersonal
Therapy (IPT), and Dialectical Behavior Therapy (DBT) for
postpartum depression. These neurobehavioral treatments focus on
addressing the maladaptive behaviors, routines, and dysfunctional
thoughts that perpetuate during postpartum depression. Integrating
and personalizing multiple therapeutic modalities, the company
provides a robust, user-centered experience, fostering better
engagement and more meaningful health outcomes. With a strong focus
on quality, regulatory compliance, and comprehensive reporting,
Curio sets new standards in women's healthcare, making it a market
leader in digital therapeutics for mental health.
"Curio platform's high adherence underscores its
effectiveness in maintaining user engagement and delivering
consistent mental health benefits. The company employs
cutting-edge neurobehavioral therapy programs to
address risk factors for
postpartum depression. The program's daily learning modules
foster essential psychological skills such as
emotion regulation, psychological flexibility, and self-compassion,
providing mothers with the tools they need to navigate the
challenges of motherhood," added Supriya
Lal Kundu, Industry Analyst at Frost & Sullivan.
Each year, Frost & Sullivan presents this award to the
company that has developed an innovative element in a product by
leveraging leading-edge technologies. The award recognizes the
value-added features/benefits of the product and the increased
return on investment (ROI) it gives customers, which, in turn,
raises customer acquisition and overall market penetration
potential.
Frost & Sullivan Best Practices awards recognize companies
in various regional and global markets for demonstrating
outstanding achievement and superior performance in leadership,
technological innovation, customer service, and strategic product
development. Industry analysts compare market participants and
measure performance through in-depth interviews, analyses, and
extensive secondary research to identify best practices in the
industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned
for its role in helping investors, corporate leaders, and
governments navigate economic changes and identify disruptive
technologies, Mega Trends, new business models, and companies to
action, resulting in a continuous flow of growth opportunities to
drive future success. Contact us: Start the discussion. Contact us:
Start the discussion.
Contact:
Ashley Shreve
E: ashley.shreve@frost.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/curio-digital-therapeutics-applauded-by-frost--sullivan-for-enhancing-womens-maternal-mental-healthcare-with-its-mamalift-and-mamalift-plus-solutions-302280978.html
SOURCE Frost & Sullivan